Get the Stockscreener App
0.6221
2.16%
0.0096
Werewolf Therapeutics Inc stock is traded at $0.6221, with a volume of 293.80K.
It is up +2.16% in the last 24 hours and up +3.25% over the past month.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
See More
Previous Close:
$0.6125
Open:
$0.6125
24h Volume:
293.80K
Relative Volume:
0.49
Market Cap:
$30.20M
Revenue:
$19.94M
Net Income/Loss:
$-37.37M
P/E Ratio:
-0.5982
EPS:
-1.04
Net Cash Flow:
$-33.38M
1W Performance:
-0.98%
1M Performance:
+3.25%
6M Performance:
-53.65%
1Y Performance:
-49.54%
1-Day Range:
$0.5833
$0.6221
1-Week Range:
$0.5416
$0.63
52-Week Range:
$0.5301
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Name
Werewolf Therapeutics Inc
Sector
Industry
Phone
617-952-0555
Address
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
0.6221 | 29.73M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.31 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
763.61 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
722.13 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.36 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.71 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Downgrade | Wedbush | Outperform → Neutral |
| Apr-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-24-23 | Initiated | Wedbush | Outperform |
| Jun-06-23 | Resumed | Jefferies | Buy |
| Sep-10-21 | Initiated | BofA Securities | Buy |
| May-25-21 | Initiated | Evercore ISI | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
| May-25-21 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | SVB Leerink | Outperform |
View All
Werewolf Therapeutics Inc Stock (HOWL) Latest News
HOWL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HOWL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is now the right time to enter Werewolf Therapeutics IncTrade Entry Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Werewolf Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Werewolf Therapeutics announces plan to explore strategic alternatives - MSN
Werewolf Therapeutics explores sale and strategic alternatives - Investing.com India
Werewolf Therapeutics Announces Plan to Explore Strategic Alternatives - Investing News Network
Werewolf Therapeutics Begins Strategic Alternatives Review Process - TipRanks
Werewolf Therapeutics (HOWL) starts review of strategic options with Piper Sandler - Stock Titan
Werewolf Therapeutics explores sale and strategic alternatives By Investing.com - Investing.com South Africa
Levels Update: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Spike Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
HOWL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Published on: 2026-02-18 21:12:16 - baoquankhu1.vn
Why Werewolf Therapeutics Inc. stock could rally in 2025Portfolio Gains Summary & Smart Swing Trading Techniques - mfd.ru
IPO Launch: Does Werewolf Therapeutics Inc have strong EBITDA margins2025 Analyst Calls & Risk Controlled Daily Plans - baoquankhu1.vn
Werewolf Therapeutics stock falls after announcing 64% workforce reduction By Investing.com - Investing.com Canada
Werewolf Therapeutics Stock Rises Over 5% After Hours On Workforce Reduction, Including Executives - Asianet Newsable
Werewolf Therapeutics stock rises over 5% after hours on workforce reduction, including executives - MSN
Werewolf Therapeutics stock falls after announcing 64% workforce reduction - Investing.com
Werewolf Therapeutics Cuts 64% of Workforce - marketscreener.com
Werewolf Therapeutics Announces Major Workforce and Leadership Restructuring - TipRanks
Werewolf Therapeutics, Inc. Announces Executive Changes, Effective February 13, 2026 - marketscreener.com
What insider trading reveals about Werewolf Therapeutics Inc. stockMarket Movers & Verified Momentum Stock Ideas - mfd.ru
What is the target price for Werewolf Therapeutics Inc. stock2025 AllTime Highs & Risk Controlled Stock Pick Alerts - mfd.ru
Is Werewolf Therapeutics Inc. impacted by rising ratesWeekly Investment Report & Safe Capital Investment Plans - mfd.ru
Aug Opening: Should I invest in Standard BioTools Inc before earningsWall Street Watch & AI Powered Market Trend Analysis - baoquankhu1.vn
Does Werewolf Therapeutics Inc. have strong EBITDA marginsJuly 2025 Final Week & Daily Stock Trend Watchlist - mfd.ru
Death Cross: Is now the right time to enter Werewolf Therapeutics Inc2025 Geopolitical Influence & Consistent Income Trade Ideas - baoquankhu1.vn
Werewolf Therapeutics (HOWL) upgraded to buy: Here's what you should know - MSN
Trading Action: Does Werewolf Therapeutics Inc have strong EBITDA marginsJuly 2025 Momentum & AI Driven Stock Price Forecasts - baoquankhu1.vn
Werewolf Therapeutics receives Nasdaq notice for minimum bid price deficiency - Investing.com Nigeria
Werewolf Therapeutics Receives Nasdaq Minimum Bid Price Notice - TipRanks
Werewolf Therapeutics Received Notice of Noncompliance - TradingView
Bond Watch: What dividend growth rate does ZENA offerInsider Buying & Weekly Momentum Stock Picks - baoquankhu1.vn
Is Werewolf Therapeutics Inc stock trending bullish2025 Market Sentiment & Free Verified High Yield Trade Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock By Investing.com - Investing.com Australia
Evnin Luke, Werewolf Therapeutics director, sells $20,942 in Howl stock - Investing.com
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Short Interest Update - Defense World
Movement Recap: Can Black Hawk Acquisition Corporation ride the EV waveGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
Werewolf Therapeutics (HOWL) price target decreased by 10.86% to 5.30 - MSN
Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k By Investing.com - Investing.com India
Evenin Luke sells Werewolf Therapeutics (HOWL) stock for $61k - Investing.com
Werewolf Therapeutics Inc Stock (HOWL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Werewolf Therapeutics Inc Stock (HOWL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| EVNIN LUKE | Director |
Jan 13 '26 |
Sale |
0.55 |
43,198 |
23,759 |
2,266,671 |
| EVNIN LUKE | Director |
Jan 15 '26 |
Sale |
0.55 |
37,413 |
20,577 |
2,198,642 |
| EVNIN LUKE | Director |
Jan 14 '26 |
Sale |
0.57 |
30,616 |
17,451 |
2,236,055 |
| EVNIN LUKE | Director |
Jan 12 '26 |
Sale |
0.57 |
58,980 |
33,619 |
2,309,869 |
| EVNIN LUKE | Director |
Jan 09 '26 |
Sale |
0.61 |
24,678 |
15,054 |
2,368,849 |
| EVNIN LUKE | Director |
Jan 08 '26 |
Sale |
0.63 |
7,716 |
4,861 |
2,393,527 |
| EVNIN LUKE | Director |
Jan 06 '26 |
Sale |
0.65 |
40,761 |
26,495 |
2,413,158 |
| EVNIN LUKE | Director |
Jan 05 '26 |
Sale |
0.64 |
18,378 |
11,762 |
2,453,919 |
| EVNIN LUKE | Director |
Jan 07 '26 |
Sale |
0.64 |
11,915 |
7,626 |
2,401,243 |
4.07%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):